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Inflammatory myofibroblastic tumor (IMT) of the biliary tree is extremely rare and is generally a benign condition, though 
malignant change is possible. Making a differential diagnosis between this lesion and other malignant conditions is very dif-
ficult on preoperative imaging studies. Hence, the final diagnosis of IMT may be made during or after operation depending 
on the pathologic examination. We treated a 63-year-old woman who received right hepatectomy with caudate lobectomy 
under the suspicion of hilar cholangiocarcinoma. Frozen biopsy during the operation showed carcinoma in situ and there 
were stromal cells in the bile duct’s resection margins. The postoperative hospital course was uneventful except for minor 
bile leakage. At postoperative month 4, she developed jaundice, ascites and pleural effusion. Computed tomography images 
showed a mass-like lesion in the porta hepatis with portal vein thrombosis and a right chest wall mass. Excisional biopsy was 
done and the pathology report was malignant spindle cell tumor suggestive of an aggressive form of IMT. Her condition rap-
idly deteriorated regardless of the best supportive care and she expired at postoperative month 5. Further investigation is 
necessary to clarify the reasons for recurrence and infiltration of this disease.
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INTRODUCTION
Inflammatory myofibroblastic tumors (IMT) are rare le-
sions with the gross appearance of a malignancy, but they 
are generally benign lesions composed of myofibroblastic 
spindle cells, plasma cells, lymphocytes and eosinophils 
[1]. This tumor was previously called plasma cell gran-
uloma, inflammatory pseudotumor and inflammatory 
myofibrohistiocytic proliferation, but IMT is the currently 
used designation [2]. Tumors located at the hilar region 
and that are complicated with obstructive jaundice are 
mostly malignant hilar cholangiocarcinoma and these tu-
mors require surgical resection if possible. The clinical 
manifestations and radiologic images of IMT are very sim-
ilar to those of a malignant lesion of the hilar biliary tract. 
So diagnosis of these lesions usually depends on the path-
ology during or after an operation. Making a differential 
diagnosis of benign and malignant tumors is not very dif-
ficult, but the final diagnosis of IMT may be somewhat 
challenging.
We report here on a patient with aggressive IMT located 
at the porta hepatis along with cholangiocarcinoma in situ Bum-Soo Kim, et al.
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Fig. 1. Computed tomograpy shows enhancing mass at confluent 
level with dilatation of both intrahepatic bile ducts dilatation of 
intrahepatic duct.
Fig. 2. Magnetic reso-
nance imaging shows 
dilatation and separa-
tion of both intrahepatic 
bile ducts.
Fig. 3. Endoscopic retrograde cholangiopancreatography findings. 
Stricture at bifurcation of hepatic duct.
of the proximal bile duct.
CASE REPORT
A 63-year-old woman was admitted to the Department 
of Surgery at Kyung Hee University Hospital for the eval-
uation of jaundice and weight loss (5 kg) during the pre-
vious 2 months. She had no relevant medical history. The 
initial liver function tests, including aspartate amino-
transferase, alanine aminotransferase, total bilirubin, γ- 
glutamyltransferase and alkaline phosphatase, were 98 
(IU/L), 290 (IU/L), 4.9 (mg/dL), 374 (IU/L) and 838 (IU/L), 
respectively.
Abdominal ultrasound examination showed dilatation 
of both the intrahepatic bile ducts. Abdominal computed 
tomography (CT) examination showed an enhancing 
mass at the confluent level with dilatation of both intra-
hepatic bile ducts, and this was all suggestive of Klatskin 
tumor type IIIa or IV (Fig. 1).
Magnetic resonance cholangiopancreatography also 
showed dilatation and separation of both intrahepatic bile 
ducts, as well as suspicion of right hepatic artery encase-
ment by the tumor (Fig. 2).
Endoscopic retrograde cholangiopancreatography was 
performed to evaluate the biliary tree and decompress the Aggressive inflammatory myofibroblastic tumor
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Fig. 5. Computed tomography shows 2 cm enhancing mass on right 
side chest wall.
Fig. 6. Inflammatory myofibroblastic tumor of soft tissue com-
posed of marked atypical spindle cells (thin arrows) with in-
tervening collagen bundles (arrow heads). Many tumor cells show 
epithelioid configuration. Mitotoic figures (thick arrows) are noted 
(H&E, ×400).
Fig. 4. (A) Inflammatory myofibroblastic tumor of liver composed 
of atypical spindle cells (arrow heads) with intervening collagen 
bundles. Mitotoic figure (thick arrow) and plasma cell infiltration 
(thin arrows) are noted (H&E, ×400). (B) Inflammatory myo-
fibroblastic tumor shows immunoreactivity for smooth muscle 
actin (polymer method, ×200). (C) Inflammatory myofibroblatic 
tumor shows immunoreactivity for vimentin (polymer method, 
×200).
jaundice. There was a stricture at the bifurcation of the 
hepatic duct, which was suggestive of a cholangiocarci-
noma of the common hepatic duct at the porta hepatis (a 
Klatskin tumor, Bismuth type IIIa). The area of stricture 
was brushed for cytology and was found to be negative. 
The guide wire could not be advanced into the right hep-
atic duct, so an endoscopic nasobiliary drainage tube was 
placed into the left hepatic duct (Fig. 3). Percutaneous 
transhepatic biliary drainage was performed for right hep-
atic duct biliary drainage. Positron emission tomography 
(PET) was done for evaluation of the lesion and to rule out 
metastasis. However, there was no visible abnormal hy-
permetabolic lesion in the porta hepatis.
The patient subsequently underwent right hepatec-
tomy with caudate lobectomy and Roux-en-Y hepaticoje-Bum-Soo Kim, et al.
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junostomy due to the high probability of hilar cholan-
giocarcinoma. The frozen biopsies of all the bile duct re-
section margins were negative existing stromal cells. The 
final pathologic diagnosis was carcinoma in situ of the bile 
duct with exuberant stromal fibrosis. Immunoreactivity 
for smooth muscle actin and vimentin was shown (Fig. 4). 
The patient was diagnosed with inflammatory myofibro-
blastic tumor with hilar bile duct carcinoma in situ. The 
hospital course was uneventful except for minor bile leak-
age and the patient was discharged without complication.
At 4 months after the initial operation, the patient was 
re-admitted for cholangitis, abdominal distension, dysp-
nea and a right chest wall mass. Abdominal CT showed a 
mass-like lesion in the porta hepatis with portal vein 
thrombosis, intrahepatic bile duct dilatation and a large 
amount of right pleural effusion with ascites. A right chest 
wall enhancing mass was detected suggestive of meta-
static lesion (Fig. 5).
Excisional biopsy was performed for the chest wall 
mass, the pathology of which was malignant spindle cell 
tumor suggestive of the aggressive form of inflammatory 
myofibroblastic tumor (Fig. 6). Immunohistochemical stai-
ning for smooth muscle actin and vimentin was positive as 
such immunohistochemical staining of the bile duct.
The patient’s condition rapidly worsened regardless of 
supportive care and she expired during the 5th post-
operative month.
DISCUSSION
IMT has been more frequently described in the lung and 
abdomen, but can also be found in the central nervous sys-
tem, salivary glands, larynx, bladder, breast, spleen, skin 
and liver [2]. The pathogenesis of IMT is controversial. 
Some previous cases were related to autoimmune disease 
and infectious disease [3,4]. IMTs at the biliopancreatic re-
gion, and especially at the distal bile duct, are usually asso-
ciated with autoimmune pancreatitis, which is believed to 
be an initial activation process, and this indicates that the 
fibroblastic cells in both lesions may have been induced at 
the same site resulting from the same inflammatory and fi-
brosing process with different histological appearances 
[3].
Whether this current case belongs to a form of chol-
angitis associated with lymphoplasmacytic sclerosing 
pancreatitis is unknown.
IMT of the bile duct is extremely rare with only limited 
cases having been reported in the literature [5]. The clin-
ical manifestations of hilar biliary duct IMT are indis-
tinguishable from those of hilar cholangiocarcinoma. 
Radiologic studies of hilar bilary IMT can not provide dif-
ferentiation between IMT and cholangiocarcinoma or 
lymphoma due to considerable similarities [6]. In this case, 
the only difference in cholangiocarcinoma was that there 
was no visible abnormal hypermetabolic lesion seen on 
PET.
Most IMTs behave as benign lesions. There is no con-
sensus on the appropriate treatment of IMT. However, 
surgical resection is the one of the preferred treatments, if 
possible. But medical treatments such as chemotherapy, 
radiation therapy, antitumor necrosis factor-α binding an-
tibody, nonsteroidal anti-inflammatory drugs or cortico-
steroids have been reported [2,7]. A very limited number 
of cases, as in this case, have demonstrated aggressive fea-
tures with a significant recurrence rate of 25%. Recurrence 
is associated with an abdominopelvic site, multinodular 
tumor masses and incomplete resection, but even IMTs 
that are only biopsied or excised with positive margins 
sometimes do not recur or progress [8].
IMT is currently regarded as a locally recurrent, rarely 
metastasizing neoplasm of intermediate malignancy [2]. 
There is a report about its different biological behavior 
that may represent a premalignant lesion [9]. In this case, 
we are not sure whether the carcinoma in situ of the bile 
duct was an incidental finding or if it was associated with 
the pathogenesis of the biliary IMT.
Microscopically, IMT consists of varying proportions of 
spindle cells, plasma cells, lymphocytes, eosinophils and 
macrophages. The spindle cells usually stain positively for 
actin and vimentin, but are negatively stained for S100. 
This case also stained positive for smooth muscle actin and 
vimentin, and negative for S100. Anaplastic lymphoma 
kinase (ALK) immunohistochemistry is relatively specific 
for IMT among the spectrum of fibroblastic-myofibro-
blastic tumors and other potential mesenchymal mimics Aggressive inflammatory myofibroblastic tumor
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of IMT [10]. The previous study indicated that ALK pos-
itive IMT was diagnosed in younger age patients and that 
it had an improved prognosis. ALK-negative IMTs were 
associated with a higher age, death due to local disease, 
and the presence of metastases [2]. Our current case 
stained negatively for ALK protein.
In conclusion, biliary IMT is extremely rare, and can be 
one of the causes of obstructive jaundice. Clinicians must 
remain aware of the aggressiveness of this disease and 
should keep an eye on the possibility of disease recur-
rence. Further investigation is necessary in order to better 
clarify the characteristics and treatment of IMT.
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